Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

McVean

Showing results (191-200 of 234) with videos related to

Pageof 24
Sort By:
Nature|July 18, 2012
TNF receptor 1 genetic risk mirrors outcome of anti-TNF therapy in multiple sclerosisAdam P Gregory, Calliope A Dendrou, Kathrine E Attfield, et al.
The American Journal of Cardiology|March 6, 2021
Validation of an Integrated Risk Tool, Including Polygenic Risk Score, for Atherosclerotic Cardiovascular Disease in Multiple Ethnicities and AncestriesMichael E Weale, Fernando Riveros-Mckay, Saskia Selzam, et al.
The Journal of Infectious Diseases|January 23, 2019
Genomic Analysis of Plasmodium vivax in Southern Ethiopia Reveals Selective Pressures in Multiple Parasite MechanismsSarah Auburn, Sisay Getachew, Richard D Pearson, et al.
Nature Genetics|April 11, 2017
Genome-to-genome analysis highlights the effect of the human innate and adaptive immune systems on the hepatitis C virusM Azim Ansari, Vincent Pedergnana, Camilla L C Ip, et al.
Science Translational Medicine|November 4, 2016
Resolving TYK2 locus genotype-to-phenotype differences in autoimmunityCalliope A Dendrou, Adrian Cortes, Lydia Shipman, et al.
Diabetes Technology & Therapeutics|May 30, 2023
Glycemic Outcomes During Early Use of the MiniMed™ 780G Advanced Hybrid Closed-Loop System with Guardian™ 4 SensorToni L Cordero, Zheng Dai, Arcelia Arrieta, et al.
Nature Communications|December 18, 2013
A rare functional cardioprotective APOC3 variant has risen in frequency in distinct population isolatesIoanna Tachmazidou, George Dedoussis, Lorraine Southam, et al.
Journal of Medicinal Chemistry|September 17, 2004
Nonpeptide alphavbeta3 antagonists. Part 11: discovery and preclinical evaluation of potent alphavbeta3 antagonists for the prevention and treatment of osteoporosisPaul J Coleman, Karen M Brashear, Ben C Askew, et al.
Diabetes Technology & Therapeutics|April 29, 2026
Safety and Effectiveness of MiniMed™ 780G Advanced Hybrid Closed-Loop Use with Ultrarapid Insulin Lispro-AABC in Pediatric and Adult Type 1 DiabetesHalis K Akturk, Laura M Nally, Rayhan A Lal, et al.
Bioorganic & Medicinal Chemistry Letters|December 12, 2001
Non-peptide alpha(v)beta(3) antagonists. Part 3: identification of potent RGD mimetics incorporating novel beta-amino acids as aspartic acid replacementsPaul J Coleman, Karen M Brashear, Cecilia A Hunt, et al.
Pageof 24

Showing results (191-200 of 234) with videos related to

Sort By:
Pageof 24
Nature|July 18, 2012
TNF receptor 1 genetic risk mirrors outcome of anti-TNF therapy in multiple sclerosisAdam P Gregory, Calliope A Dendrou, Kathrine E Attfield, et al.
The American Journal of Cardiology|March 6, 2021
Validation of an Integrated Risk Tool, Including Polygenic Risk Score, for Atherosclerotic Cardiovascular Disease in Multiple Ethnicities and AncestriesMichael E Weale, Fernando Riveros-Mckay, Saskia Selzam, et al.
The Journal of Infectious Diseases|January 23, 2019
Genomic Analysis of Plasmodium vivax in Southern Ethiopia Reveals Selective Pressures in Multiple Parasite MechanismsSarah Auburn, Sisay Getachew, Richard D Pearson, et al.
Nature Genetics|April 11, 2017
Genome-to-genome analysis highlights the effect of the human innate and adaptive immune systems on the hepatitis C virusM Azim Ansari, Vincent Pedergnana, Camilla L C Ip, et al.
Science Translational Medicine|November 4, 2016
Resolving TYK2 locus genotype-to-phenotype differences in autoimmunityCalliope A Dendrou, Adrian Cortes, Lydia Shipman, et al.
Diabetes Technology & Therapeutics|May 30, 2023
Glycemic Outcomes During Early Use of the MiniMed™ 780G Advanced Hybrid Closed-Loop System with Guardian™ 4 SensorToni L Cordero, Zheng Dai, Arcelia Arrieta, et al.
Nature Communications|December 18, 2013
A rare functional cardioprotective APOC3 variant has risen in frequency in distinct population isolatesIoanna Tachmazidou, George Dedoussis, Lorraine Southam, et al.
Journal of Medicinal Chemistry|September 17, 2004
Nonpeptide alphavbeta3 antagonists. Part 11: discovery and preclinical evaluation of potent alphavbeta3 antagonists for the prevention and treatment of osteoporosisPaul J Coleman, Karen M Brashear, Ben C Askew, et al.
Diabetes Technology & Therapeutics|April 29, 2026
Safety and Effectiveness of MiniMed™ 780G Advanced Hybrid Closed-Loop Use with Ultrarapid Insulin Lispro-AABC in Pediatric and Adult Type 1 DiabetesHalis K Akturk, Laura M Nally, Rayhan A Lal, et al.
Bioorganic & Medicinal Chemistry Letters|December 12, 2001
Non-peptide alpha(v)beta(3) antagonists. Part 3: identification of potent RGD mimetics incorporating novel beta-amino acids as aspartic acid replacementsPaul J Coleman, Karen M Brashear, Cecilia A Hunt, et al.
Pageof 24